Kernodle Katon Asset Management Group buys $1,005,374 stake in Cardinal Health Inc (CAH)

Cardinal Health Inc (CAH) : Kernodle Katon Asset Management Group scooped up 11,350 additional shares in Cardinal Health Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 11, 2016. The investment management firm now holds a total of 12,026 shares of Cardinal Health Inc which is valued at $1,005,374.Cardinal Health Inc makes up approximately 0.91% of Kernodle Katon Asset Management Group’s portfolio.

Other Hedge Funds, Including , Teachers Advisors Inc boosted its stake in CAH in the latest quarter, The investment management firm added 19,582 additional shares and now holds a total of 663,956 shares of Cardinal Health Inc which is valued at $55,506,722. Cardinal Health Inc makes up approx 0.09% of Teachers Advisors Inc’s portfolio.Ameritas Investment Partners boosted its stake in CAH in the latest quarter, The investment management firm added 299 additional shares and now holds a total of 6,441 shares of Cardinal Health Inc which is valued at $538,468. Cardinal Health Inc makes up approx 0.03% of Ameritas Investment Partners’s portfolio. Taylor Wealth Management Partners sold out all of its stake in CAH during the most recent quarter. The investment firm sold 600 shares of CAH which is valued $50,784.Brighton Jones reduced its stake in CAH by selling 268 shares or 8.94% in the most recent quarter. The Hedge Fund company now holds 2,729 shares of CAH which is valued at $230,983. Cardinal Health Inc makes up approx 0.04% of Brighton Jones’s portfolio.

Cardinal Health Inc closed down -0.13 points or -0.16% at $82.02 with 8,99,566 shares getting traded on Tuesday. Post opening the session at $82.39, the shares hit an intraday low of $82 and an intraday high of $82.56 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.

On the company’s financial health, Cardinal Health Inc reported $1.14 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Aug 2, 2016. Analyst had a consensus of $1.13. The company had revenue of $31384.00 million for the quarter, compared to analysts expectations of $31167.11 million. The company’s revenue was up 13.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.00 EPS.

Investors should note that on Aug 8, 2016, Cardinal Health Inc announced a cash dividend of $0.4489. The company’s management has announced Sep 29, 2016 as the ex-dividend date and fixed the record date on Oct 3, 2016. The payable date has been fixed on Oct 15, 2016.

Many Wall Street Analysts have commented on Cardinal Health Inc. Cardinal Health Inc was Resumed by BofA/Merrill to “Neutral” on Jun 7, 2016.

Cardinal Health Inc. is a healthcare services and products company. The Company operates in two segments: Pharmaceutical and Medical. The Company also provides medical products to patients in the home. In the United States the Company’s Pharmaceutical segment distributes branded and generic pharmaceutical over-the-counter healthcare and consumer products through its Pharmaceutical Distribution division to retailers hospitals and other healthcare providers. In China the Pharmaceutical segment distributes branded generic and specialty pharmaceutical over-the-counter healthcare and consumer products provides logistics marketing and other services and operates direct-to-patient specialty pharmacies through Cardinal Health China. The Medical segment distributes a range of medical surgical and laboratory products and provides services to hospitals ambulatory surgery centers clinical laboratories and other healthcare providers.

Leave a Reply

Cardinal Health Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Cardinal Health Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.